Organoid-based platforms for drug discovery, preclinical testing, and personalized medicine
AyuBio was founded on the belief that scientific discovery holds the greatest value when it bridges the gap between research and meaningful patient impact. Our mission is to advance translational research by developing human-derived models that support the journey from laboratory discovery to clinical application. Guided by science, innovation, and collaboration, we strive to equip researchers with physiologically relevant tools that contribute to a deeper understanding of disease and more informed therapeutic development.
We envision a future where advances in biomedical research translate into tangible benefits for patients. By supporting researchers with reliable and relevant biological models, we aim to contribute to the development of safer therapies, deeper disease understanding, and a more informed approach to precision medicine.
Developing models derived from human tissues to support translational research.
Enabling disease modeling and preclinical research using advanced organoid technologies.
Research to better understand disease biology and treatment response.
Working alongside researchers and industry partners to advance biomedical innovation.
Derived from individual patient tissues, patient-derived organoids provide physiologically relevant models for disease research, drug screening, biomarker discovery, and personalized medicine.
Established directly from patient tissues, these 2D cultures support microenvironment and are widely used for disease modeling, drug evaluation, and toxicity assessment.
Human cell spheroids recreate key aspects of the tissue assay development, organoid generation, and a range of downstream research workflows.
Dissociated cell stocks provide a flexible starting material for cell culture, individual patient tissues, patient-derived organoids provide physiologically relevant models for disease research, drug screening, biomarker discovery, and personalized medicine.
Founder/Chairman
Founder/V.Chairman
Founder/Director of Marketing and Business Development
Founder/Director of Facilities Management and Procurement
MSc in Molecular and Cellular Life Sciences
Utrecht University, Netherlands
MS in Pharmaceutical Sciences
University of Maryland, Baltimore, USA
BBA in Logistics & Supply Chain Management
Diploma in Automobile Engineering
Organoids retain the structure and genetics of real patient tissue, making them more predictive of clinical outcomes.
Yes. We offer custom development based on your target disease, tissue type, and assay needs.
Our platforms support high-throughput workflows and are designed to scale with your project.
We’re actively engaged with regulators and provide documentation to support preclinical submissions.
All samples are ethically sourced through IRB-approved protocols in partnership with clinical providers.
Ayubio Lifesciences Pvt. Ltd.
CSIR - Innovation Complex,
3rd Floor, Lokhandwala Road, 4 Bungalows, next to Ambani Hospital, SV Patel Nagar, Andheri West, Mumbai, Maharashtra 400053
+91 7021796709
vbondal@ayubio.in
Interested in learning more about our research and platforms? Get in touch, and our team will be happy to connect with you.
Ayubio Lifesciences Pvt. Ltd.
© 2026 . All right Reserve. Site Developed by TEAMAK
